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Geminin Becomes Activated as an Inhibitor
of Cdt1/RLF-B Following Nuclear Import
is released from the nuclei, so the PIEs contain a mixture
of both cytoplasmic and nucleoplasmic proteins (data
not shown). When DNA was present during the preincu-
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and J. Julian Blow1
Cancer Research UK Chromosome Replication
Research Group bation, the resultant PIE contained a potent inhibitor of
Wellcome Trust Biocentre replication licensing (Figure 1A) and blocked the loading
University of Dundee of Mcm3 onto chromatin (Figure 1B). In contrast, when
Dow Street no DNA was present in the preincubation, no licensing
Dundee DD1 5EH inhibitor was generated. The PIE had no inhibitory effect
United Kingdom on the replication of licensed DNA templates, sug-
gesting that the inhibitory activity is specific for licensing
(data not shown).
Summary Since the inhibitory activity first appeared around the
time that nuclear assembly was completed (data not
During late mitosis and early interphase, origins of shown), we investigated whether nuclear assembly is
replication become “licensed” for DNA replication by involved in its generation. Ran T24N, a mutant Ran pro-
loading Mcm2-7 complexes [1–5]. Mcm2-7 complexes tein stabilized predominantly in the GDP-bound form,
are removed from origins as replication forks initiate inhibits nuclear assembly in Xenopus extract [12, 13].
replication, thus preventing rereplication of DNA in a Figure 1A shows that, when extract was preincubated
single cell cycle. Premature origin licensing is pre- for 90 min with sperm nuclei and Ran T24N protein, no
vented in metaphase by the action of geminin, which licensing inhibitor was generated. In contrast, wild-type
binds and inhibits Cdt1/RLF-B, a protein that is re- Ran (which does not block nuclear assembly) did not
quired for the loading of Mcm2-7 [6–9]. Recombinant block the appearance of the inhibitor. Wheat germ ag-
geminin that is added to Xenopus egg extracts is effi- glutinin, a lectin that binds to nuclear pores, inhibits
ciently degraded upon exit from metaphase [10]. Here, nuclear protein transport and nuclear envelope assem-
we show that recombinant and endogenous forms of bly [14]. No licensing inhibitor was generated when DNA
Xenopus geminin behave differently from one another, was preincubated in extract supplemented with wheat
such that a significant proportion of endogenous gem- germ agglutinin (Figure 1A). The concentration of wheat
inin escapes proteolysis upon exit from metaphase. germ agglutinin used in this experiment was sufficient
During late mitosis and early G1, the surviving popula- to inhibit DNA replication and gross nuclear swelling but
tion of endogenous geminin does not associate with did not block complete nuclear envelope assembly (data
Cdt1/RLF-B and does not inhibit licensing. Following not shown), suggesting that inhibition of nuclear trans-
nuclear assembly, geminin is imported into nuclei and port was responsible for the effect. Similarly, when
becomes reactivated to bind Cdt1/RLF-B. This reacti- sperm nuclei were incubated in extract lacking nuclear
vated geminin provides the major nucleoplasmic in- envelope precursors (membrane-free extract), no licens-
hibitor of origin relicensing during late interphase. ing inhibitor was generated (Figure 1A). Taken together,
Since the initiation of replication at licensed origins these results suggest that nuclear assembly and nuclear
depends on nuclear assembly [11], our results suggest transport are required for generation of the inhibitory
an elegant and novel mechanism for preventing rerep- activity in preincubated extracts.
lication of DNA in a single cell cycle. We next investigated whether the inhibitory activity is
localized in the nucleus. Nucleoplasmic and cytoplasmic
Results fractions of Xenopus egg extracts can be prepared by
floating intact nuclei through the cytoplasm by gentle
DNA-Dependent Generation of an Inhibitor centrifugation [15]. Hard centrifugation of the nuclear
of Replication Licensing fraction then separates it into a soluble nucleoplasmic
As part of our studies into how relicensing of replicated extract and an insoluble pellet. When preincubated ex-
DNA is prevented in G2, we investigated whether the tract was fractionated in this way, most of the licensing
presence of DNA in Xenopus extract affected further inhibitor present in preincubated extracts was seen to
replication licensing. Extract was supplemented with be concentrated in the nucleoplasmic extract (Figure
cycloheximide (to arrest extracts in G2 phase) plus or 1C). It was of interest that Cdk2 and geminin (both poten-
minus sperm nuclei and was incubated for 90 min. Ex- tial licensing inhibitors) were also concentrated within
tract was then diluted and the chromatin was removed the nucleoplasmic extract (Figure 1D).
by centrifugation to generate a “preincubated extract”
(PIE). In this protocol, almost all of the soluble protein
The Licensing Inhibitor Is Geminin
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Figure 1. DNA-Dependent Generation of an
Inhibitor of Replication Licensing
(A) Whole extract or membrane-free extract
was preincubated with or without sperm nu-
clei (10 ng DNA/l)  2.5 M wild-type or
T24N mutant Ran or 200 g/ml wheat germ
agglutinin. The ability of the PIEs to inhibit
licensing in untreated interphase extracts
was measured. The dashed line represents
background licensing of sperm nuclei incu-
bated in buffer alone.
(B) Sperm nuclei were incubated for 30 min in
interphase extract supplemented with either
buffer or PIE. Chromatin was isolated and
immunoblotted for Orc1, Cdc6, Mcm3, Cdt1,
and geminin.
(C) PIE, nucleoplasmic extract, and cyto-
plasmic extract were subject to serial 3-fold
dilutions, then assayed for their ability to in-
hibit licensing of interphase extract. The
dashed line represents background licensing
of sperm nuclei incubated in buffer alone.
(D) Cytoplasmic extract, nucleoplasmic ex-
tract, and the insoluble nuclear pellet were
immunoblotted for Orc1, Cdc6, Cdt1, Mcm7,
geminin, and CDKs (PSTAIR).
CDK activity, we used the specific CDK inhibitor roscovi- tory activity generated in G2 as a result of nuclear as-
sembly and nuclear transport.tine [16]. Although 2.5 mM roscovitine is sufficient to
inhibit the initiation of DNA replication [16], it did not We were surprised to find geminin in our extracts,
since geminin was originally identified in a screen forblock the appearance of the licensing inhibitor (Figure
2A, PIE  rosc.). Similar results were obtained with the proteins specifically degraded at the metaphase-to-
anaphase transition [10] and our extracts were supple-CDK inhibitor p21Cip1 (data not shown). Interphase ex-
tracts were depleted of ORC, Cdc6, Cdt1, Mcm3, Mcm7, mented with cycloheximide to prevent any new protein
synthesis. We noted, however, that the assays per-or Cdc7, or were mock depleted with nonimmune serum.
When DNA was preincubated in each of these extracts, formed by McGarry and Kirschner [10] involved the deg-
radation of recombinant geminin, while the degradationa potent licensing inhibitor was still generated (Figure 2A),
suggesting that generation of the licensing inhibitor is not of endogenous geminin was not reported. To confirm
that our extracts could efficiently degrade recombinantdependent on any known aspect of pre-RC assembly.
The major inhibitor of origin licensing present in meta- geminin upon exit from metaphase, two forms of 6xHis-
tagged geminin protein were produced in Escherichiaphase Xenopus egg extract is geminin [9]. Figure 2A
shows that interphase extracts immunodepleted of coli: one wild-type (Figure 2B, lane 1), and one con-
taining a mutation in its destruction box to make it resis-geminin failed to generate the licensing inhibitor after
preincubation with DNA. In addition, when inhibitory tant to degradation (gemininDEL, Figure 2B, lane 4) [10].
When incubated in extracts exiting from metaphase, thePIEs prepared from untreated extract were subse-
quently depleted of geminin, the inhibitory activity was wild-type recombinant protein was almost completely
degraded, while the DEL mutant remained stable (Figurelost (Figure 2A, PIE, geminin). The addition of recombi-
nant Cdt1 (the target of geminin inhibition) to PIE reacti- 2B, lanes 2 and 5). In contrast, both proteins remained
stable when incubated for an equivalent period of timevated its ability to assemble Mcm7 onto sperm chroma-
tin (Figure 2A, inset). When similar experiments were in interphase extract (Figure 2B, lanes 3 and 6). These
results are consistent with the efficient cell cycle-spe-performed on nucleoplasmic fractions, immunodeple-
tion of geminin removed the licensing inhibitor, while cific degradation of recombinant geminin reported by
McGarry and Kirschner [10].inhibition of CDKs did not (Figure S1). These results
therefore show that geminin provides the major inhibi- However, in these experiments, significant quantities
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Figure 2. The Licensing Inhibitor Is Geminin
(A) The ability of various preincubated ex-
tracts to inhibit replication licensing was as-
sayed. Sperm nuclei were preincubated in in-
terphase extract  2.5 mM roscovitine (PIE,
PIE rosc.). Alternatively, sperm nuclei were
preincubated in interphase extract previously
depleted with antibodies against Orc1, Cdc6,
Mcm3, Mcm7, Cdc7, or geminin, or mock de-
pleted with nonimmune antibodies (NI), or
extract previously depleted of Cdt1 using
geminin-coupled beads. Alternatively, PIE
was prepared in normal interphase extract
and was then depleted with either anti-gemi-
nin antibodies (PIE, geminin) or nonimmune
antibodies (PIE, NI). Inset: immunoblot of
chromatin-bound Mcm7 following 30 min of
incubation of sperm nuclei in PIE (lane 1),
PIE  recombinant Cdt1 (lane 2), or PIE pre-
pared without DNA (lane 3).
(B) Wild-type and gemininDEL (which lacks a
functional destruction box) were incubated
at 1.3 ng/l for 45 min in metaphase extract
released into interphase with CaCl2 (lanes 2
and 5) or interphase extract (lanes 3 and 6).
Input levels of recombinant geminin are
shown in lanes 1 and 4. Samples were ana-
lyzed by SDS-PAGE and immunoblotted with
anti-geminin antibodies (top panel) or anti-
6xHis antibodies (bottom panel).
(C) Metaphase extract (M) sperm nuclei (10
ng DNA/l) was released into interphase by
the addition of CaCl2, and, at the indicated
times (in min), aliquots were taken and immu-
noblotted for endogenous geminin and Cdt1.
of endogenous geminin remained in the extract (Figure peak of500 kDa. Geminin was observed in two peaks,
61% in a large peak cofractionating with Cdt1/RLF-B,2B, upper panel, lanes 2 and 3). The quantity of endoge-
nous geminin and Cdt1/RLF-B present in extracts was and the rest in a smaller peak without Cdt1/RLF-B (Fig-
ure 3A). The smaller peak migrated in the same positiontherefore measured at different times after exit from
metaphase arrest in vitro (Figure 2C). Although some as free recombinant geminin (data not shown). This sug-
gests that, in metaphase, Cdt1/RLF-B is fully boundgeminin degradation was clearly observed upon exit
from metaphase, 30%–60% of endogenous geminin re- and inhibited by geminin and that there is also excess
geminin activity present [9]. Upon exit from metaphasesisted degradation. We also noticed a slight decline in
the amount of Cdt1/RLF-B, consistent with the loss of into interphase, some, but not all, geminin was de-
graded, but 95% of the remaining geminin was foundRLF-B activity seen when preincubations were per-
formed without added DNA [17]. The presence of sperm in the smaller complex (Figure 3B). Further, the endoge-
nous Cdt1/RLF-B migrated as a slightly smaller com-nuclei in the extract had no significant effect on the
degree of degradation observed (Figure 2C). We con- plex, consistent with it no longer binding geminin. When
extract was preincubated with DNA, so that gemininclude that a significant quantity of endogenous geminin
escapes degradation, and that this geminin is incapable once again inhibited Cdt1/RLF-B, the fractionation pat-
tern again resembled that seen in metaphase, with allof inhibiting licensing until nuclear assembly occurs.
the Cdt1/RLF-B and 45% geminin cofractionating in
the larger complex (Figure 3C). Immunodepletion experi-Geminin’s Inhibitory Activity Correlates with Its
Ability to Interact with Cdt1/RLF-B ments showed that, under these conditions, a complex
between Cdt1/RLF-B and geminin had reformed (FigureIf some endogenous geminin escapes degradation in
anaphase, why does it not inhibit licensing? A change S2). In contrast, when extract was preincubated in the
absence of DNA, most geminin and Cdt1/RLF-B didin its ability to interact with Cdt1/RLF-B could provide
a potential explanation. We therefore examined the be- not cofractionate, though some complex (24% of the
geminin) was formed (Figure 3D). Coprecipitation alsohavior of geminin and Cdt1/RLF-B by gel filtration. In
metaphase-arrested extracts, Cdt1 migrated in a single showed a significant quantity of free Cdt1 in the absence
Brief Communication
681
Figure 3. Geminin’s Affinity for Cdt1 Changes
during the Cell Cycle
(A–D) Gel filtration of different extracts immu-
noblotted for geminin and Cdt1: (A) meta-
phase extract, (B) interphase extract (10 min
after metaphase release), (C) preincubated
extract plus sperm (10 ng DNA/l, 90 min),
and (D) preincubated extract minus sperm (no
DNA, 90 min). The migration of molecular
weight markers (in kDa) is shown above.
(E) Preincubated extracts were prepared 
10 ng DNA/l at the indicate times; 6xHis-
Cdt1 was added and incubated for 30 min,
then pulled out on Ni-NTA agarose. Bead-
bound Cdt1 and geminin were analyzed by
SDS-PAGE and immunoblotting.
of DNA (Figure S2). We therefore see a good correspon- Discussion
dence between the presence of inhibitory activity and
the cofractionation of Cdt1/RLF-B and geminin. Replication licensing requires ORC to bind origin DNA,
Since recombinant geminin can bind Cdt1/RLF-B and which in turn permits the recruitment of Cdc6 and Cdt1/
inhibit licensing when added to early interphase Xeno- RLF-B, and eventually the loading of Mcm2-7 [1–5].
pus extracts [9, 10], we reasoned that endogenous gemi- While each of the different components can potentially
nin might become altered during late mitosis and early be regulated [5], previous studies have indicated that
interphase so that it is unable to bind Cdt1/RLF-B. To origin licensing is controlled within the Xenopus embry-
address this, extract was preincubated plus or minus onic cell cycle, predominantly by the regulation of Cdt1/
DNA for either 5 or 90 min. Recombinant 6xHis-Cdt1 RLF-B activity [9, 17, 18]. Cdt1/RLF-B is specifically
was added to these PIEs and was then collected on Ni- bound and inhibited by geminin, and this provides the
agarose beads. Bead-bound material was immunoblot- major mechanism by which origin licensing is regulated
ted to determine whether endogenous geminin had during metaphase [9]. Geminin was originally identified
bound to the recombinant Cdt1. Figure 3E shows that, in a screen for recombinant proteins degraded upon exit
when nuclear assembly did not occur (either because from mitosis in Xenopus egg extracts [10]. However,
no DNA was present or because insufficient time had this earlier study did not investigate the degradation of
elapsed to allow nuclei to assemble), endogenous gemi- endogenous geminin in the Xenopus system. We dem-
onstrate here that, although recombinant geminin is effi-nin did not bind significantly to the recombinant Cdt1.
However, when nuclear assembly occurred and the in- ciently degraded by Xenopus egg extracts upon exit
from metaphase, a significant proportion of endogenoushibitor was activated, a significant quantity of endoge-
nous geminin was bound to the recombinant Cdt1 (Fig- geminin escapes degradation. This is different from
what is observed in somatic cells, where geminin ap-ure 3E, lane 5). This suggests that, as a consequence
of nuclear assembly, endogenous geminin becomes pears to be virtually absent throughout G1 [10, 19].
Despite the continued presence of endogenous gemi-competent for inhibition of Cdt1/RLF-B.
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tively, there may be another protein that is activated
upon exit from metaphase that modulates the activity
of geminin in a noncovalent way.
We also show that endogenous geminin regains the
capacity to bind recombinant Cdt1 and inhibit further
origin licensing when it has been imported into an in-
terphase nucleus (Figure 4C). It is possible that the fac-
tor(s) required to inactivate geminin are excluded from
interphase nuclei, thus allowing the alteration that had
occurred upon metaphase exit to become reversed in-
side the nucleus. The reactivation of geminin did not
depend on CDK activity, distinguishing this mechanism
from what has been reported in yeast, where high nu-
clear CDK activity is required to prevent reassembly of
pre-RCs and relicensing of replicated DNA [2, 3, 5]. This
parallels earlier work showing that geminin is the major
inhibitor of origin licensing in metaphase-arrested Xeno-
pus egg extracts [9]. Since the initiation of DNA replica-
tion only takes place within the nucleus [11], the reacti-
vation of geminin as a licensing inhibitor in the nucleus
provides an elegant mechanism for preventing rereplica-
tion of DNA.
Experimental Procedures
Preparation of Egg Extracts and Sperm Nuclei
Metaphase-arrested and interphase low-speed supernatant Xeno-
pus egg extracts were prepared as described [21]. Extracts wereFigure 4. Model for Geminin Regulation during the Xenopus Embry-
supplemented with 250 g/ml cycloheximide, 25 mM phosphocre-onic Cell Cycle
atine, and 10g/ml creatine phosphokinase before use, and incuba-A cartoon showing a small segment of chromatin containing a repli-
tions were performed at 23. 6-DMAP-treated extract was preparedcation origin as it passes through the cell cycle. Hexagons labelled
by supplementing metaphase-arrested extracts with 3 mM 6-DMAP,“M” represent hexameric complexes of Mcm2-7.
[-32P]dATP, and 0.3 mM CaCl2 [20]. Xenopus sperm nuclei were(A) In metaphase, geminin is both abundant and active, so it is able
demembranated with lysolecithin as described [21] and frozen into inhibit origin licensing by formation of a tight complex with Cdt1/
aliquots in liquid nitrogen. Preincubated extracts (PIEs) were pre-RLF-B. ORC and Cdc6 do not bind tightly to DNA, probably due to
pared by incubating interphase extract with sperm nuclei at 10 nghigh CDK levels.
DNA/l for 90 min. Extracts were then diluted by the addition of 3(B) Upon metaphase release, some of the geminin is degraded, but
vol ice-cold LFB2/50 (40 mM HEPES KOH [pH 8.0], 50 mM KCl, 20the remaining geminin is altered in some way that prevents it from
mM K2HPO4/KH2PO4 [pH 8.0], 2 mM MgCl2, 1 mM EGTA, 2 mM DTT,binding and inhibiting Cdt1/RLF-B. The loss of CDK activity allows
2.5 mM Mg-ATP, 10% sucrose, and 1 g/ml each of leupeptin,ORC and Cdc6 to associate tightly with DNA. With all components
pepstatin, and aprotinin). The diluted extracts were then transferredof the licensing system active, Mcm2-7 is loaded onto origins.
to precooled polycarbonate centrifuge tubes (Beckman #343775)(C) Following nuclear assembly, geminin is imported into a functional
and centrifuged at 72,000 rpm (30,000  g) using a TLA-100 rotornucleus and becomes reactivated. This allows it to bind and inhibit
(Beckman) for 20 min at 4C. The supernatant was recovered andCdt1/RLF-B, thus preventing the relicensing of replicated origins.
snap frozen in 10 l beads in liquid nitrogen.
Membrane-free extracts were prepared by 3-fold dilution of ex-
tract in LFB2/50, followed by centrifugation at 72,000 rpmnin, Cdt1/RLF-B activity appears abruptly upon exit from
(230,000  g) using a TLA-100 rotor (Beckman) for 20 min at 4C.metaphase [17, 20]. We show here that, as Cdt1/RLF-B
Nucleoplasmic extract and cytoplasmic extract were prepared asbecomes activated upon exit from metaphase, it changes
previously described [15]. Immunodepletion of interphase extracts,
from being in a complex with geminin to a form where PIE, and nucleoplasmic extract with antibodies raised against XOrc1
it is not. When recombinant geminin is added to early [22], XCdc6 [18], XMcm3 [23], XMcm7 [24], geminin [9], or with
antibodies from nonimmune rabbit serum was performed as de-interphase Xenopus egg extracts, it forms a complex
scribed [21]. Extract was depleted of Cdt1 using geminin-coupledwith endogenous Cdt1/RLF-B and strongly inhibits li-
beads as described [9].censing [9, 10]. In contrast, we show here that, when
recombinant Cdt1/RLF-B is added to the extract, it binds
Licensing Assaysendogenous geminin only very poorly. This suggests
Licensing inhibition assays were performed essentially as describedthat, upon exit from metaphase, geminin is altered in
[21]. Briefly, 2-l fractions of interest were incubated with 0.4 l
some way that prevents it binding to and inhibiting Cdt1/ interphase extract and 0.3 l sperm nuclei (80 ng DNA/l) for 30
RLF-B. This change leads to the abrupt activation of min. The degree of licensing was then assessed by the addition of
6 l 6-DMAP-treated extract containing [-32P]dATP and incubationorigin licensing upon exit from metaphase (Figures 4A
for 90 min; total DNA synthesis was measured by scintillation count-and 4B). It is possible that this geminin alteration is also
ing of acid-insoluble material.responsible for protecting it from degradation. Although
To investigate chromatin binding, licensing assays were scaledwe have detected different forms of geminin on two-
up 10-fold to a total volume of 24 l. After 30 min of incubation,
dimensional gels, we have so far been unable to identify each reaction was diluted in 300 l NIBA (50 mM KCl, 50 mM HEPES
a covalent modification that strictly correlates with the KOH [pH 7.6], 5 mM MgCl2, 2 mM DTT, 0.5 mM spermidine, 0.15
mM spermine, 2.5 mM Mg-ATP, and 1 g/ml each of leupeptin,changes in activity (A.L., unpublished data). Alterna-
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1454.The chromatin was pelleted at 3,500  g in a swinging bucket rotor
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